MacroGenics expects cash runway through 2028

MGNX•2026-11-13

MacroGenics expects its cash runway to extend through 2028. It had $288 million in cash equivalents and marketable securities as of September 30, 2026, and generated $359 million in non-dilutive capital in 2025-2026.

MacroGenics expects cash runway through 2028

1. Cash runway outlook

Related News

Datavault AI receives notice of Nasdaq trading suspension; stock eligible to trade on OTC markets

Evofem swings to Q3 net income of $1 million

Azio AI Holdings holds annual shareholder meeting

Sources

MacroGenics expects cash runway through 2028

Health insurers rise as US temporarily eases Medicaid work-rule enforcement

AT&T sues Comcast over 'fiber-powered' internet advertising